FDA-cleared profile

BriefCase-Quantification

Aidoc Medical, Ltd. · CT/CTA · FDA-cleared (510(k))

Authorized purpose: Assist appropriately trained medical specialists by providing the maximum abdominal aortic axial diameter from contrast-enhanced CT exams that include the abdominal aorta in adults or transitional adolescents aged 18 years and older; evaluate normal and aneurysmal abdominal aortas, not postoperative aortas, and do not use results alone for clinical decisions.

Clinical role
Parallel measurement/quantification adjunct that provides a preview of the maximum axial abdominal-aortic diameter for PACS review; the radiologist reviews full images and the official report remains final.
Images and patients
CT/CTA · Abdominal aorta
Key limitation
Keep in mind: Not intended to evaluate postoperative aortas. The measurement is unofficial and not final, must be reviewed against full images and other clinical information by a radiologist, and must not be used standalone or to preclude clinical assessment; final approved measurements come from the official radiology report. The FDA packet does not establish a specific current PACS, RIS, EHR, or deployment configuration beyond the described cloud-server workflow.

Overview status: Source-reviewed overview

Report a correction
Clinical details Purpose, workflow fit, evidence, and safety record

Workflow navigation pilot

Workflow role has not yet been reviewed for this navigation pilot.

A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources

  • What does this software do?Authorized purpose: Assist appropriately trained medical specialists by providing the maximum abdominal aortic axial diameter from contrast-enhanced CT exams that include the abdominal aorta in adults or transitional adolescents aged 18 years and older; evaluate normal and aneurysmal abdominal aortas, not postoperative aortas, and do not use results alone for clinical decisions.
  • Which images or clinical context are in scope?Modality: CT/CTA Anatomy or clinical context: Abdominal aorta Input: Filtered DICOM images from contrast-enhanced CT exams including the abdominal aorta, in adults or transitional adolescents aged 18 years and older; relevant series are processed chronologically.
  • Who uses it?Intended users: Appropriately trained medical specialists
  • What does the software produce?Output: A preview image annotated with the maximum axial abdominal-aortic diameter measurement, forwarded to an image-review application and PACS; the original unmarked series remains available, and the preview is labeled unofficial, not final, and for review by a radiologist.
  • What is its most important limitation?Key limitation: Not intended to evaluate postoperative aortas. The measurement is unofficial and not final, must be reviewed against full images and other clinical information by a radiologist, and must not be used standalone or to preclude clinical assessment; final approved measurements come from the official radiology report. The FDA packet does not establish a specific current PACS, RIS, EHR, or deployment configuration beyond the described cloud-server workflow.

Clinical takeaway. Clinical role: Assist appropriately trained medical specialists by providing the maximum abdominal aortic axial diameter from contrast-enhanced CT exams that include the abdominal aorta in adults or transitional adolescents aged 18 years and older; evaluate normal and aneurysmal abdominal aortas, not postoperative aortas, and do not use results alone for clinical decisions.

Evidence takeaway. Evidence from the reviewed source record: FDA K230534 reports a retrospective, blinded, multicenter study of 160 CT cases from six US academic and community clinical sites, with ground truth determined by three US board-certified radiologists. The primary endpoint mean absolute error was 1.95 mm (95% CI 1.59-2.32 mm) and met the prespecified performance goal. The validation cohort mean age was 66.8 years, and scanner counts were Siemens 52, GE 46, Philips 39, and Toshiba 23.

Evidence context

Evidence context not reviewed for this FDA record.

Public-label constraints

Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.

Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.

Purpose
Assist appropriately trained medical specialists by providing the maximum abdominal aortic axial diameter from contrast-enhanced CT exams that include the abdominal aorta in adults or transitional adolescents aged 18 years and older; evaluate normal and aneurysmal abdominal aortas, not postoperative aortas, and do not use results alone for clinical decisions.
  • Exact FDA submission
  • Checked 2026-09-08
Workflow role
Parallel measurement/quantification adjunct that provides a preview of the maximum axial abdominal-aortic diameter for PACS review; the radiologist reviews full images and the official report remains final.
  • Exact FDA submission
  • Checked 2026-09-08
Required input
Filtered DICOM images from contrast-enhanced CT exams including the abdominal aorta, in adults or transitional adolescents aged 18 years and older; relevant series are processed chronologically.
  • Exact FDA submission
  • Checked 2026-09-08
Output and clinician action
A preview image annotated with the maximum axial abdominal-aortic diameter measurement, forwarded to an image-review application and PACS; the original unmarked series remains available, and the preview is labeled unofficial, not final, and for review by a radiologist.
  • Exact FDA submission
  • Checked 2026-09-08
Care setting
Clinical radiology workflow; the FDA validation used six US academic and community clinical sites but does not establish a required facility type
  • Exact FDA submission
  • Checked 2026-09-08
Intended users
Appropriately trained medical specialists
  • Exact FDA submission
  • Checked 2026-09-08
Limitations
Not intended to evaluate postoperative aortas. The measurement is unofficial and not final, must be reviewed against full images and other clinical information by a radiologist, and must not be used standalone or to preclude clinical assessment; final approved measurements come from the official radiology report. The FDA packet does not establish a specific current PACS, RIS, EHR, or deployment configuration beyond the described cloud-server workflow.
  • Exact FDA submission
  • Checked 2026-09-08
Evidence summary
FDA K230534 reports a retrospective, blinded, multicenter study of 160 CT cases from six US academic and community clinical sites, with ground truth determined by three US board-certified radiologists. The primary endpoint mean absolute error was 1.95 mm (95% CI 1.59-2.32 mm) and met the prespecified performance goal. The validation cohort mean age was 66.8 years, and scanner counts were Siemens 52, GE 46, Philips 39, and Toshiba 23.
  • Exact FDA submission
  • Checked 2026-09-08

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
FDA K230534 reports a retrospective, blinded, multicenter study of 160 CT cases from six US academic and community clinical sites, with ground truth determined by three US board-certified radiologists. The primary endpoint mean absolute error was 1.95 mm (95% CI 1.59-2.32 mm) and met the prespecified performance goal. The validation cohort mean age was 66.8 years, and scanner counts were Siemens 52, GE 46, Philips 39, and Toshiba 23.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-08
Reported sensitivity
Research pending
  • Needs research
  • Exact FDA submission
  • Checked 2026-08-31

This field has not been curated yet.

Reported specificity
Research pending
  • Needs research
  • Exact FDA submission
  • Checked 2026-08-31

This field has not been curated yet.

No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.

BriefCase-Quantification of the Abdominal Aortic Measurement (M-AbdAo) regulatory performance study summary

  • DesignStand-Alone Performance
  • PopulationAdult
  • Scopeexact submission
  • Tested versionExact product version not reported; regulatory study summarized for FDA submission K230534
  • Samplen=160
  • Sites6
  • IndependenceIndependence not established

K230534

ACR AI Central summarizes the regulatory study; consult the exact FDA materials before comparative use.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
The exact-identifier FDA recall query returned no native recall record for K230534. This limited result does not establish absence of recalls or other safety information and does not cover later versions, family records, MAUDE reports, corrections, or field notices.
  • Public source
  • Exact FDA submission
  • Checked 2026-09-08
Pricing & contracts Public price, contract terms, and reimbursement

Price not public here; enter your quote

Not verified: Pricing information is recorded but not verified against a resolving source.

Reimbursement

IT implementation Deployment, interfaces, data handling, and support

System and version relationships

Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.

No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.

Review Merge, Visage, Sectra, AGFA and IntelePACS context

Integration chain: evidence at each hop

Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.

Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner

No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.

  1. Acquisition/source

    Source context, not route validation: Filtered DICOM images from contrast-enhanced CT exams including the abdominal aorta, in adults or transitional adolescents aged 18 years and older; relevant series are processed chronologically.

    Scope: Exact FDA submission.

    Confirm scanner/model, protocol, series completeness and both software builds.

    Field checked 2026-09-08 · FDA K230534: BriefCase-Quantification

  2. Routing

    Source context, not route validation: The device runs as a Linux-based server in a cloud environment, receives filtered DICOM images, transfers analysis to an image-review desktop application, and forwards results to a PACS destination for medical-specialist review. Exact PACS products, interfaces, versions, hosting region, and current data flow are not established.

    Scope: Exact FDA submission.

    Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.

    Field checked 2026-09-08 · FDA K230534: BriefCase-Quantification

  3. AI processing

    Source context, not route validation: The exact FDA package describes BriefCase-Quantification as intended to run on a Linux-based server in a cloud environment. Current hosting, data flow, and commercial configuration require vendor confirmation.

    Scope: Exact FDA submission. Packet wording: "to run on a linux-based server in a cloud environment". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.

    Confirm processing location, queue ownership, exclusions and exact AI build.

    Field checked 2026-11-14 · FDA K230534: BriefCase-Quantification

  4. Returned objects

    Source context, not route validation: A preview image annotated with the maximum axial abdominal-aortic diameter measurement, forwarded to an image-review application and PACS; the original unmarked series remains available, and the preview is labeled unofficial, not final, and for review by a radiologist.

    Scope: Exact FDA submission.

    Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.

    Field checked 2026-09-08 · FDA K230534: BriefCase-Quantification

  5. Viewer/worklist/report

    Unresolved route: A preview image annotated with the maximum axial abdominal-aortic diameter measurement, forwarded to an image-review application and PACS; the original unmarked series remains available, and the preview is labeled unofficial, not final, and for review by a radiologist.

    Scope: Exact FDA submission.

    Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.

    Field checked 2026-09-08 · FDA K230534: BriefCase-Quantification

  6. Support owner

    Unresolved route: Not established for the exact route.

    Scope: Scope not established.

    Name the local, platform and AI supplier support owners and escalation path.

Planned local route tests

No tests below have been performed or accepted.

  1. Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
  2. Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
  3. Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
  4. Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
  5. Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
  6. Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
  7. Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.

Local implementation checklist

Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.

Open the printable evaluation checklist

Deployment
The exact FDA package describes BriefCase-Quantification as intended to run on a Linux-based server in a cloud environment. Current hosting, data flow, and commercial configuration require vendor confirmation.
  • Exact FDA submission
  • Checked 2026-11-14

Packet wording: "to run on a linux-based server in a cloud environment". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.

Integration
The device runs as a Linux-based server in a cloud environment, receives filtered DICOM images, transfers analysis to an image-review desktop application, and forwards results to a PACS destination for medical-specialist review. Exact PACS products, interfaces, versions, hosting region, and current data flow are not established.
  • Exact FDA submission
  • Checked 2026-09-08
Security
Aidoc's current public Security & Privacy page says its security work is led by a CISO and security team, that it has adopted the NIST Cybersecurity Framework, and that its platform runs on AWS and Azure using EDR, encryption, SIEM and CSPM tooling. The page's list of standards and certifications did not load as readable text, so no certification is stated here.
  • Vendor-wide
  • Checked 2026-10-25

Vendor-wide marketing statement, not an independent attestation. It does not establish certificate scope or expiry, the controls of this exact release, data location, retention, identity and access, or incident-response terms for a deployed configuration. Obtain these from the vendor.

Monitoring
Aidoc's security page states that its platform runs on AWS and Azure and that customer data protection is achieved with the use of EDR, encryption, SIEM, CSPM and other technologies.
  • Vendor-wide
  • Checked 2026-10-27

Vendor statement, not an attestation. The page names Aidoc's platform generally and does not scope these capabilities to any specific product release; exact-release scope is not established. The page lists technology categories in use; it states no uptime, alerting or response-time SLAs.

Result destination

PACS is explicitly referenced as a result destination.

exact submission · checked 2026-09-01

Confirm supported products, versions, routing behavior, and display requirements during local evaluation.

ACR exact-submission catalog context

ACR AI Central provides an exact-submission model card for BriefCase-Quantification; FDA labeling remains controlling for clinical use, limitations, and performance.

exact submission · checked 2026-09-08
Sources & review details FDA identity, research record, source ledger, and history

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K230534
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
CT/CTA
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-08
Anatomy
Abdominal aorta
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-08
Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2023-11-08
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Exact FDA record reviewedStatus
2026-09-20Last searched
21Fields reviewed
10Source classes checked
0Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads

The refreshed discovery snapshot contains no PubMed or ClinicalTrials.gov candidates; no external evidence was promoted. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, fda decision summary, acr ai central product, vendor product page, fda device recall, literature index, trial registry, pubmed, clinical trials, openfda device recall

Field review details

Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.

  • Public pricing: Not verified - checked 2026-09-08 - Exact FDA submission

    No public price or quote for the exact K230534 configuration was established in this review.

  • Pricing model: Not yet reviewed
  • Setup and integration fees: Not yet reviewed
  • Recurring fees: Not yet reviewed
  • Minimum commitment: Not yet reviewed
  • Contract duration: Not yet reviewed
  • Renewal terms: Not yet reviewed
  • Cancellation terms: Not yet reviewed
  • Support and service terms: Not yet reviewed
  • Trial or pilot terms: Not yet reviewed
  • Reimbursement: Not publicly available - checked 2026-09-08 - Exact FDA submission

    No exact-product payer policy, coding instruction, or payment determination was established; eligibility must be evaluated by payer, site of service, and use case.

  • Data hosting location: Not yet reviewed
  • Data retention: Not yet reviewed
  • Documented data use: Not yet reviewed
  • Hardware requirements: Not yet reviewed
  • Network requirements: Not yet reviewed
  • Identity and access: Not yet reviewed
  • Installation timeline: Not yet reviewed
  • Training: Not verified - checked 2026-09-08 - Exact FDA submission

    Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.

8 sources - 3 history items

Source ledger

  1. FDA K230534: BriefCase-Quantification

    U.S. Food and Drug Administration - Published 2023-11-08 - Accessed 2026-09-08

    Scope: identity, clinicalUse, modality, anatomy, workflow, evidence, implementation, deployment

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. BriefCase-Quantification of the Abdominal Aortic Measurement (M-AbdAo) model card (K230534)

    American College of Radiology - Published 2026-06-26 - Accessed 2026-09-01

    Scope: careSetting, output, evidenceSummary, integration, anatomy, evidenceStudies, implementationCapabilities

  4. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  5. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  6. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

  7. openFDA exact recall query for K230534

    U.S. Food and Drug Administration - Accessed 2026-09-08

    Scope: postmarketSafety

  8. Aidoc Security & Privacy

    Aidoc Medical - Accessed 2026-10-25

    Scope: security

Research history

  1. K230534 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    fda record reviewed

  3. Reader overview source-reviewed

    Editorial review

    Source-reviewed editorial overlay

Alternatives

Related tools to compare

FDA-cleared K241112

BriefCase-Quantification

Aidoc Medical, Ltd.

Authorized purpose: Analyzes contrast CT exams containing the abdominal aorta and provides maximum abdominal-aortic diameter measurement.

Modality
CT/CTA
Anatomy
Abdominal aorta
Decision
2024-05-15
FDA-cleared K253560

Enhanced Boundary for PCCT

Ge Medical Systems, LLC

Authorized purpose: Enhanced Boundary for PCCT is a deep-learning CT processing function for improved soft-tissue delineation in routine head examinations with or without contrast.

Modality
CT/CTA
Anatomy
Head
Decision
2026-06-24
FDA-cleared K253649

Spectral CT Verida Family

Philips Medical Systems Technologies, Ltd.

Authorized purpose: Spectral CT Verida Family supports the labeled spectral CT acquisition, reconstruction, material-map, and professional-interpretation workflow; exact models, protocols, and derived outputs remain submission-specific.

Modality
CT/CTA
Anatomy
Multi-region
Decision
2026-03-27
FDA-cleared K253574

SOMATOM X.cite; SOMATOM X.ceed

Siemens Medical Solutions USA, Inc.

Authorized purpose: SOMATOM X.cite and X.ceed with syngo CT VB20 support diagnostic CT, interventions, treatment preparation, radiation-therapy planning, and qualified low-dose lung screening.

Modality
CT/CTA
Anatomy
Multi-region
Decision
2026-03-20

Correct this exact record

Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.

Open existing correction destination

Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.

Accepted repository change history

No entry has been added to this scoped change history for this record. This is not proof that the record never changed.

Correction policy and limits · Public repository change history